Therapeutic drug monitoring as a measure of proactive pharmacovigilance in child and adolescent psychiatry-Reference-Cited by-同舟云学术

Therapeutic drug monitoring as a measure of proactive pharmacovigilance in child and adolescent psychiatry

Published:2016-08-26 Issue:11 Volume:15 Page:1477-1482
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Gerlach Manfred¹,Egberts Karin¹,Dang Su-Yin¹,Plener Paul²,Taurines Regina¹,Mehler-Wex Claudia¹³,Romanos Marcel¹

Affiliation:

1. Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Centre for Mental Health, University Hospital of Würzburg, Würzburg, Germany

2. Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Germany

3. HEMERA Private Hospital for Mental Health, Adolescents and Young Adults, Bad Kissingen, Germany

Funder

German Federal Ministry of Education and Research

German Federal Institute for Drugs and Medical Devices

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2016.1225721

Reference31 articles.

1. AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011

2. Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring

3. Drug monitoring in child and adolescent psychiatry for improved efficacy and safety of psychopharmacotherapy

4. Special Features of Psychopharmacological Therapy in Children and Adolescents

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial;Pharmaceutics;2023-08-25

2. Therapeutic drug monitoring in adolescents with anorexia nervosa for safe treatment with adjunct olanzapine;European Eating Disorders Review;2023-08-17

3. Clinical pharmacokinetics of antipsychotics in pediatric populations: a scoping review focusing on dosing regimen;Expert Opinion on Drug Metabolism & Toxicology;2023-08-03

4. CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis;Pharmaceuticals;2023-07-03

5. Entwicklungspsychopharmakologie;Neuro-/Psychopharmaka im Kindes- und Jugendalter;2023